These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3104249)

  • 1. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
    Leibel S; Bauer M; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Pakuris E; Conner N
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):541-9. PubMed ID: 3104249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
    Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.
    Bauer M; Leibel S; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Conner N; Pakuris E
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1101-3. PubMed ID: 3528087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
    Stehman FB; Bundy BN; Keys H; Currie JL; Mortel R; Creasman WT
    Am J Obstet Gynecol; 1988 Jul; 159(1):87-94. PubMed ID: 3293456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix.
    Overgaard J; Bentzen SM; Kolstad P; Kjoerstad K; Davy M; Bertelsen K; Mäntyla M; Frankendal B; Skryten A; Löftquist I
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1069-72. PubMed ID: 2649463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.
    Chan P; Milosevic M; Fyles A; Carson J; Pintilie M; Rauth M; Thomas G
    Radiother Oncol; 2004 Mar; 70(3):295-9. PubMed ID: 15064016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
    Logsdon MD; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial.
    Simpson JR; Bauer M; Perez CA; Wasserman TH; Emami B; Doggett RL; Byhardt RW; Phillips TL; Mowry PA
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1483-91. PubMed ID: 2542197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT; Jones B; Gee A; Kingston RE
    Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
    Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
    Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
    Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical irradiation and misonidazole in the treatment of advanced cervical carcinoma: results of a phase II trial.
    Girinski T; Pejovic MH; Haie C; Bonnay M; Gerbaulet A; Mazeron JJ; Malaise E; Chassagne D
    Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1783-7. PubMed ID: 4044341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study.
    DiSaia PJ; Bundy BN; Curry SL; Schlaerth J; Thigpen JT
    Gynecol Oncol; 1987 Mar; 26(3):386-97. PubMed ID: 3549476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.